Literature DB >> 560239

The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.

V Höllt, A Czlonkowski, A Herz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 560239     DOI： 10.1016/0006-8993(77)90855-1

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  7 in total

1.  PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.

Authors:  H H Coenen; K Wienhard; G Stöcklin; P Laufer; I Hebold; G Pawlik; W D Heiss
Journal:  Eur J Nucl Med       Date:  1988

2.  Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.

Authors:  O Inoue; K Kobayashi; H Tsukada; T Itoh; B Langstrom
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Specific in vivo binding of d-LSD in rat brain.

Authors:  K Kräuchi; H Feer; M Lichtsteiner; A Wirz-Justice
Journal:  Experientia       Date:  1978-06-15

4.  Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium.

Authors:  C Gulat-Marnay; A Lafitte; J C Schwartz; P Protais
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

5.  Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.

Authors:  M G Ondrusek; C D Kilts; G D Frye; R B Mailman; R A Mueller; G R Breese
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.

Authors:  J Chivers; P Jenner; C D Marsden
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

7.  Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.

Authors:  L Farde; E Ehrin; L Eriksson; T Greitz; H Hall; C G Hedström; J E Litton; G Sedvall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.